# Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography

> **NCT02282163** · PHASE3 · TERMINATED · sponsor: **Bracco Diagnostics, Inc** · enrollment: 13 (actual)

## Conditions studied

- Heart Disease

## Interventions

- **DRUG:** sulphur hexafluoride lipid-type A microspheres

## Key facts

- **NCT ID:** NCT02282163
- **Lead sponsor:** Bracco Diagnostics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2018-05-31
- **Final completion:** 2018-08
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** FDA agreed to early termination due to difficulties enrolling patients.
- **Last updated:** 2020-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02282163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02282163, "Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02282163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*